<DOC>
	<DOCNO>NCT02388191</DOCNO>
	<brief_summary>The purpose study : 1 . To evaluate whether 550 mg naproxen sodium reduces pain score IUD insertion 0-10cm visual analogue scale compare placebo ( primary outcome ) . 2 . To evaluate whether 550 mg naproxen sodium reduces pain score tenaculum placement , uterine sound post-procedurally 0-10 cm visual analog scale compare placebo ( secondary outcome ) . 3 . To establish prophylactic naproxen sodium acceptable routine use prior IUD insertion . Hypothesis : The administration naproxen sodium , 550mg orally , 1 hour prior IUD insertion lead reduction pain score associate IUD insertion compare placebo .</brief_summary>
	<brief_title>Naproxen Pain Control With Intrauterine Device Insertion</brief_title>
	<detailed_description />
	<mesh_term>Naproxen</mesh_term>
	<criteria>Age 18 year old Premenopausal Presenting insertion IUD type ( i.e . Mirena , Paragard , Skyla ) Englishspeaking nonEnglish speaking appropriate translator available Currently pregnant pregnant within last 4 week Not eligible IUD insertion per PPLM 's clinical protocol Presenting IUD removal reinsertion Any diagnosis chronic pain ( include fibromyalgia , endometriosis , dysmenorrhea , irritable bowel syndrome , interstitial cystitis ) Pain medication take within 12 hour enrollment Misoprostol usage within 24 hour enrollment Any known allergy contraindication nonsteroidal antiinflammatory drug ( include active renal disease , active hepatic disease , gastric ulcer disease gastritis , bleed disorder )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Contraception</keyword>
	<keyword>Naproxen</keyword>
	<keyword>Intrauterine device</keyword>
	<keyword>Pain Control</keyword>
</DOC>